Business Standard

Fredun Pharmaceuticals Share Price

Know More
NSEBSE
Stock not traded

789.3018.30 (2.37%)

12:00 AM,16th Apr 2024

BSE : 539730

NSE :

Sector : Health care

ISIN Code : INE194R01017

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Apr 16 2024 | 12:00 AM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

10

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

0.00

All Time High Date

Invalid date

All Time Low

0.00

All Time Low Date

Invalid date

Fredun Pharmaceuticals Ltd

Incorporated in 1987 as a private limited company Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma a proprietary firm for the manufacture and export of pharmaceutical formulations. Since 1993 D N Pharma's operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy. The Company has an unique range of products from niche formulations anti-diabetics to the latest antiretroviral and anti - Hypertensive products. It supplies finished formulations to over 42 Countries globally. It is associated with many Governments of different countries which have also realised the need for robust and consistent healthcare systems.The Company was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets capsules dry-syrups and ointments. It then set up a formulation unit at Palghar (Thane District) Maharashtra which commenced commercial production in Aug.'94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters including Merind.In Apr.'96 the company came out with a public issue to register its products in the overseas market for exports; to part-finance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of company's turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal Tanzaniya Uganda & Sri Lanka.In 2013 Company launched 36 new products and filed 60 new products for registration. It launched a herbal dietary supplement in Africa. During 2015 three new granulation departments were introduced to the existing two departments. It launched 19 new products under the Cosmeceuticals OEM Division in 2023. It introduced 14 new products in the pet pharmaceuticals line with another 36 in the works. It launched 16 products into the Pet Treat and Nutritional Supplement category.

Fredun Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

369

EPS - TTM (₹) [S]

30.85

P/E Ratio (X) [S]

3.32

Face Value (₹) 10
Latest Dividend (%)7.00
Latest Dividend Date 22 Sep 2023
Dividend Yield (%) 0.09
Book Value Share (₹) [S]237.79
P/B Ratio (₹) [S]3.32
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

757.00

797.00

Week Low/High

755.00

834.00

Month Low/High

695.00

901.00

Year Low/High

650.00

1249.00

All time Low/High

12.50

1428.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-0.92%%-2.33-2.19%
1 Month8.69%%0.410.57%
3 Month-6.48%%-0.250.52%
6 Month-7.78%%10.2412.24%
1 Year-13.17%%20.7124.23%
3 Year76.14%%49.3851.51%

Company Info

Company Information

Chairman & Managing Director : Daulat N Medhora

Executive Director : Nariman B Medhora

Non-Exec. & Independent Dir. : Aspi N Raimalwala

Managing Director & CFO : Fredun N Medhora

Non-Exec. & Independent Dir. : Rohinton Kanga

Company Sec. & Compli. Officer : Jinkal Shah

Additional Director : Daisy Dsouza

Registered Office: 26 Manoj Industrial Premises, G D Ambedkar Marg Wadala,Mumbai,Maharashtra-400031 Ph: 91-22-40318111

Email:business@fredungroup.com

URL:http://www.fredungroup.com